TREM2 contributes to the age-related microglial activation, the phagocytic oxidative burst, and the loss of neurons with possible detrimental effects during physiological aging, and were recently found to increase the risk for developing AD (Leyns et al., 2017; Linnartz-Gerlach et al., 2019). Here, TREM2 is linked to Alzheimer disease.